Talking Points on Deprescribing in Hospice Care

Häftad, Engelska, 2024

Av Deepak Shrivastava, USA) Shrivastava, Deepak (UC Davis School of Medicine, Sacramento, California

529 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)

Inbunden

1 159 kr

Skickas inom 7-10 vardagar

Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications. It highlights the positive intervention of reducing polypharmacy, improving a terminally ill patient's quality of life, providing individual patient context and helping clinicians in deprescribing. It discusses good ethics, patient wishes and side effect protocols to discontinue no longer relevant medications, thus improving decision-making with the goal of enhancing the patient's quality of life during the time when it is needed the most.Key Features:Empowers the patient, their families, and the providers to have an open discussion about well-informed decision-making.Equips the hospice and palliative care clinicians to comfortably explain the rationale and the discontinuation process of the unessential medications.Highlights the most important facts in bullets along with a unique feature of providing ready-to-go conversational phrases.

Produktinformation

Utgivningsdatum2024-04-23
Mått129 x 198 x 15 mm
Vikt453 g
FormatHäftad
SpråkEngelska
Antal sidor169
FörlagTaylor & Francis Ltd
ISBN9781032491059

Tillhör följande kategorier

Psykiatri inom Medicin
Omvårdnad inom Medicin
Samhällsmedicin och preventiv medicin inom Medicin
Palliativ medicin inom Medicin
Medicinsk etik och läkaretik inom Medicin

Deepak Shrivastava, MD is a board-certified Hospice Medical Director. In addition, he holds board certifications in Internal Medicine, Sleep Medicine, Pulmonary and Critical Care Medicine and Post-Acute and Long-Term Care. He is an academic and clinical faculty at the Sleep, Critical Care and Pulmonary division. He is a Clinical Professor at the University of California. He is an adjunct Professor of Pharmacy at the University of Pacific, School of Pharmacy. He is the recipient of many academic and service awards including the Medical Director of the Year award (2015) at the American Medical Directors Association. Dr. Shrivastava received his training at the State University of New York, University of California, Davis and Stanford. He is an active researcher with a keen interest in medical education. He is directly involved in health care quality and performance improvement. In addition to his active practice of Pulmonary, Critical Care and Sleep Medicine in an ACGME-accredited teaching program, he has been involved in Medicare Hospice Benefit Program since 1989. He is a member of the National Partnership for Healthcare and Hospice Innovation (NPHI). His areas of interest are clinical nursing and hospice physician education, and performance improvement in hospice care.

IntroductionPhysiologic changes of terminal illnessFundamentals of deprescribingDeprescribing StatinsDeprescribing BenzodiazepinesDeprescribing AntipsychoticsDeprescribing SSRI and SNRIsDeprescribing Tricyclic AntidepressantsDeprescribing Anticholinergic drugs for parkinsonismDeprescribing Anticholinergic drugs for urinary incontinenceDeprescribing muscle relaxantsDeprescribing long-term OpioidsDeprescribing Proton Pump InhibitorsDeprescribing AllopurinolDeprescribing Antihyperglycemics OralDeprescribing Antihyperglycemics InjectableDeprescribing anti-hypertensivesDeprescribing AnticoagulantsDeprescribing Cholinesterase inhibitorsDeprescribing Glaucoma eye dropsDeprescribing Vitamin D and CalciumDeprescribing NSAIDsDeprescribing gabapentin and pregabalinDeprescribing long-acting Beta agonistDeprescribing VitaminsDeprescribing medications in childrenDeprescribing in Transgender and LGBTQCultural competency in deprescribingChaplain and medical social workerWhen to restart discontinued medications.Medicolegal aspects of deprescribing